Commentary

Podcast

Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments

Expert discussed benefits of precision oncology treatments that utilize thousands of biomarkers to design personalized treatment plans.

About the Expert

John Oertle, NMD, is the Chief Medical Officer of Envita Medical Center — an advanced cancer and Lyme disease treatment center specializing in holistic, personalized care to improve patient outcome.

John Oertle, NMD, Chief Medical Officer of Envita Medical Center, discussed the rising rates of lung cancer in young adults, including non-smokers. Oertle explained how Envita's precision oncology model utilizes thousands of biomarkers to develop personalized treatment plans, leading to significantly improved outcomes compared to standard care. He also emphasized important risk factors like environmental exposures and infections, as well as the importance of early cancer screening and adopting healthy lifestyle habits to reduce cancer risks.

Related Videos